Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
174
datasets available to search
ShareScore release 0.9.0
Dataset results
174 results for “Neurofibromatosis I”
Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
ClinicalTrials.gov study NCT00314119. IPD Sharing: YES. Countries: 1. Publications: 1.
Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1
ClinicalTrials.gov study NCT04954001. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Neurofibromatosis Type 1 Tumor Early Detection Study
ClinicalTrials.gov study NCT06515860. IPD Sharing: UNDECIDED. Countries: 1. Publications: 7.
Systematically Assessing Changes in Plexiform Neurofibroma Related Disfigurement From Photographs of Subjects With Neurofibromatosis Type 1 on a Phase 2 Clinical Trial
ClinicalTrials.gov study NCT04879160. IPD Sharing: YES. Countries: 1. Publications: 1.
Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas
ClinicalTrials.gov study NCT00727233. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing
ClinicalTrials.gov study NCT03406208. IPD Sharing: NO. Countries: 1. Publications: 12.
Predictive modeling for clinical features associated with Neurofibromatosis Type 1
Open the record for dataset details and reuse information.
Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas
ClinicalTrials.gov study NCT01275586. IPD Sharing: NO. Countries: 1. Publications: 0.
A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (N
ClinicalTrials.gov study NCT03672838. IPD Sharing: YES. Countries: 1. Publications: 0.
Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1
ClinicalTrials.gov study NCT05912400. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of INFUSE Bone Graft (BMP-2) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF1)
ClinicalTrials.gov study NCT02718131. IPD Sharing: NO. Countries: 2. Publications: 0.
Clinical Study on the Treatment of Type I Neurofibromatosis With Smeitinib Hydrosulfate Capsule
ClinicalTrials.gov study NCT06620354. IPD Sharing: NO. Countries: 0. Publications: 15.
The Clinical Study of the Treatment of Patients With Type I Neurofibromatosis With Smetinib Hydrosulfate Capsule
ClinicalTrials.gov study NCT06621082. IPD Sharing: NO. Countries: 0. Publications: 14.
HIFU Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1: Safety and Efficacy
ClinicalTrials.gov study NCT05119582. IPD Sharing: NO. Countries: 2. Publications: 0.
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
ClinicalTrials.gov study NCT00326872. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trametinib in Patients With Advanced Neurofibromatosis Type 1 (NF1)-Mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03232892. IPD Sharing: NO. Countries: 1. Publications: 0.
Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)
ClinicalTrials.gov study NCT03109301. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas
ClinicalTrials.gov study NCT00030264. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain
ClinicalTrials.gov study NCT02471339. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
ClinicalTrials.gov study NCT04283669. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.